Issue Navigation
-
Review
-
208-212
Artificial intelligence technology in Alzheimer's disease research
Zhang WL, Li YF, Ren WT, Liu B
Intractable Rare Dis Res. 2023; 12(4):208-212.
DOI: 10.5582/irdr.2023.01091
-
213-221
Tanaka H, Shimaoka M
Intractable Rare Dis Res. 2023; 12(4):213-221.
DOI: 10.5582/irdr.2023.01068
-
222-233
Zhang S, Zhang Y, Yang D, Zhi W, Li J, Liu M, Lu Y, Han J
Intractable Rare Dis Res. 2023; 12(4):222-233.
DOI: 10.5582/irdr.2023.01076
-
234-240
Zhang S, Wang Y, Liu M, Du Z, Lu Y, Sun P, Han J
Intractable Rare Dis Res. 2023; 12(4):234-240.
DOI: 10.5582/irdr.2023.01092
-
241-245
Tanaka M, Inaba Y, Yariyama A, Nakatani Y, Kunimoto K, Kaminaka C, Yamamoto Y, Makino S, Fukushima S, Jinnin M
Intractable Rare Dis Res. 2023; 12(4):241-245.
DOI: 10.5582/irdr.2023.01056
-
246-250
Shoji H, Matsuo K, Matsushita T, Fukushima Y, Fukuda K, Abe T, Oguri S, Baba M
Intractable Rare Dis Res. 2023; 12(4):246-250.
DOI: 10.5582/irdr.2023.01090
-
251-256
Release and impact of China's "Second List of Rare Diseases"
Tang M, Yang Y, Ye Z, Song P, Jin C, Kang Q, He J
Intractable Rare Dis Res. 2023; 12(4):251-256.
DOI: 10.5582/irdr.2023.01086
-
257-261
Vosoritide, a miracle drug, covering unmet need in achondroplasia: A regulatory update
Simran, Devi SSK, Chetan Dushantrao S, Joga R, Kumar S
Intractable Rare Dis Res. 2023; 12(4):257-261.
DOI: 10.5582/irdr.2023.01055
-
262-266
Trofinetide in Rett syndrome: A brief review of safety and efficacy
Singh A, Balasundaram MK, Gupta D
Intractable Rare Dis Res. 2023; 12(4):262-266.
DOI: 10.5582/irdr.2023.01060
-
267-270
Pathologic features and clinical treatment of sarcomatoid intrahepatic cholangiocarcinoma
Xie XL, Lai NN, Yang YY, Zhang JW, Qin JM, Sheng X
Intractable Rare Dis Res. 2023; 12(4):267-270.
DOI: 10.5582/irdr.2023.01094